Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials
Overman, M. J., Morris, V., Kee, B., Fogelman, D., Xiao, L., Eng, C., Dasari, A., Shroff, R., Mazard, T., Shaw, K., Vilar, E., Raghav, K., Shureiqi, I., Liang, L., Mills, G. B., Wolff, R. A., HamiltonLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw073
Date:
February, 2016
File:
PDF, 213 KB
english, 2016